About Us
SEP provides access and integration of novel technologies to advance research. By accommodating both US and international time zones, SEP executes both pilot and large-scale projects with timely communication, reporting, and competitive pricing.
Mission
SEP goes beyond the talk to provide our partners with high quality, consolidated preclinical solutions. We focus on providing conventional and new-age imaging techniques all under one roof to answer the research question efficiently and effectively.
Vision
SEP helps pharmaceutical companies find ways to reduce their expensive internal research costs, by providing streamlined experiments using imaging technologies and other services to carry the program through to regulatory submission and approval. Companies find high value in SEP's approach, since it saves time and cost.
Founder
Stefan T. Linehan
Stefan is the founder of SEP and has been working in the preclinical ADME (DMPK) and toxicology space for over 25 years. He is well known for his advocacy of using novel imaging techniques to answer research questions, along with his development and expertise with the 3D cryo-imaging and autoradiography techniques.
Stefan served as President, President-elect, Secretary, and Webmaster for the Society for Whole Body Autoradiography (SWBA) and has held multiple Executive Committee Officer positions since 2003. He was a co-founder and Executive Committee Councilor for the Imaging Mass Spectrometry Society (IMSS).
